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Crystal structure prediction (CSP) studies are not limited to
being a search for the most thermodynamically stable crystal
structure, but play a valuable role in understanding poly-
morphism, as shown by interdisciplinary studies where the
crystal energy landscape has been explored experimentally
and computationally. CSP usually produces more thermo-
dynamically plausible crystal structures than known poly-
morphs. This article illustrates some reasons why: because (i)
of approximations in the calculations, particularly the neglect
of thermal effects (see x1.1); (ii) of the molecular rearrange-
ment during nucleation and growth (see x1.2); (iii) the solid-
state structures observed show dynamic or static disorder,
stacking faults, other defects or are not crystalline and so
represent more than one calculated structure (see x1.3); (iv)
the structures are metastable relative to other molecular
compositions (see x1.4); (v) the right crystallization experi-
ment has not yet been performed (see x1.5) or (vi) cannot be
performed (see x1.6) and the possibility (vii) that the
polymorphs are not detected or structurally characterized
(see x1.7). Thus, we can only aspire to a general predictive
theory for polymorphism, as this appears to require a
quantitative understanding of the kinetic factors involved in
all possible multi-component crystallizations. For a specific
molecule, analysis of the crystal energy landscape shows the
potential complexity of its crystallization behaviour.
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1. Introduction
Organic crystal structure prediction (CSP) software has not
advanced conceptually since its early days when we were
seeking to predict THE crystal structure from the chemical
diagram (Day, 2011; Price, 2008b). It was based on the
hypothesis that the crystal structure was the most thermo-
dynamically stable structure, and at that time the hope was
that this structure would be significantly more stable than any
other (Fig. 1a). Algorithm design concentrated on finding
effective methods of searching through the vast multi-
dimensional surface for the most stable structure, which is a
major task even if the search is restricted to the most common
space groups and packing arrangements with one small rigid
molecule in the asymmetric unit cell. The unexpected emer-
gence of crystals of a new polymorph of the anti-HIV drug
ritonavir a few years into manufacture (Bauer et al., 2001)
forcibly reminded us that metastable polymorphs could
appear to be kinetically stable, and hence CSP methods could
have a valuable practical application in providing reassurance
that the most stable polymorph was known.
Polymorphism, the ability of a molecule to crystallize in
more than one structure, is important because of the differ-
ence in physical properties between the polymorphs. These
differences can affect the uses, processing and characterization
of the crystalline material (Bernstein, 2002; Brittain, 2009;
Hilfiker, 2006; Storey & Yme´n, 2012). The prevalence of
polymorphism, as judged from thermal analysis, vibrational
spectroscopy or powder X-ray diffraction and with modern
screening methods (Stahly, 2007), is an order of magnitude
greater than would be estimated from the Cambridge Struc-
tural Database (CSD; Allen, 2002; van de Streek & Mother-
well, 2005). Despite considerable advances in the ability to
solve structures from smaller, more weakly diffracting crystals
and powders, the CSD is still dominated by reports of the
structure of the first crystal suitable for single-crystal diffrac-
tion experiments that could be grown: a bias that is worth
noting considering that CSD surveys are often used in CSP to
justify reducing the search to common space groups, Z0 = 1
(one molecule in the asymmetric unit cell) or limit the range of
molecular conformations considered. Determining the crystal
structures of metastable polymorphs can be difficult: one of
the most highly studied polymorphic systems, nicknamed
ROY [(I), for all molecular diagrams see Fig. 2] because of the
red–orange–yellow colours of the seven polymorphs whose
crystal structures are known, has at least three further poly-
morphs (Yu, 2010), although the experimental evidence is not
sufficient to tell whether they are amongst the unobserved
low-energy structures on the crystal energy landscape (Vasi-
leiadis et al., 2012). The increasing desire to explore the range
of crystal forms of a given molecule, in the search for new
materials with improved properties or for intellectual property
considerations, has led to the development of a ‘dazzling
panoply’ (Bernstein, 2011) of new techniques for growing
crystals with the aim of obtaining new forms (Llina`s &
Goodman, 2008) or obtaining better control over the poly-
morph produced (Chen et al., 2011).
The blind tests of our ability to predict a crystal structure
from the chemical diagram, organized by the Cambridge
Crystallographic Data Centre (Bardwell et al., 2011), clearly
show that the search for the most stable structure almost
always generates structures that are mechanically stable, local
minima in the lattice energy sufficiently close in energy to the
global minimum to be plausible polymorphs. Indeed, it is the
exceptions that ‘prove the rule’. For example, the structure of
the only polymorph of pigment yellow 74 (II) has such good
packing of the bumps into the hollows that this irregular, rigid
molecule forms a surprisingly well close packed plane, and the
large energy gap (about 12 kJ mol1) shows that the electro-
static forces strongly favour one mode of stacking (Schmidt,
1999). That it is unusual for a molecule to have one unique,
strongly favourable way of packing with itself can also be seen
from comparing the CSP generated packings in chiral and
non-chiral space groups (D’Oria et al., 2010). An analysis for
three molecules that spontaneously resolve showed that the
energetic favourability of the observed structures was very
small – although a molecule’s shape and interactions can
favour a chiral packing in one or two dimensions, it is hard to
imagine a molecule which can close pack with strong inter-
actions giving a favourable chiral packing in all three dimen-
sions. For example, a molecule’s structure may favour the
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Figure 1
Contrasting results of CSP studies, showing the lattice energies of the
generated structures against the packing coefficient (Gavezzotti, 1983),
with the observed structures circled in red. (a) Only one structure is
thermodynamically plausible. The experimental structure of isocaffeine
(XVb) is clearly predicted. (b) Whilst the observed structure is the most
stable, there are other structures on the crystal energy landscape
requiring consideration as to whether they could be observed
polymorphs. The crystal structures of GSK269984B (XI) are classified
by their conformation, a torsion angle that strongly affects the gross
conformation and the carboxylic acid conformation. Since the thermo-
dynamically competitive structures have very different gross conforma-
tions, these crystal structures would be expected to be long-lived if they
crystallized (Ismail et al., 2013). (c) There is a cluster of layer crystal
structures around the global minimum, requiring analysis as to whether
they could crystallize as distinct polymorphs or might lead to disorder.
Both polymorphs of caffeine (XVa) are disordered layer structures. The
crystal structures are classified according to their molecular stacking
(Habgood, 2011).
formation of helical columns, but spontaneous resolution
requires that the functional groups on the outside of these
columns also favour chiral packing in both other dimensions.
Crystal engineers (Desiraju, 2007) acknowledge that the
problem in designing a one-component organic crystal is to
find molecules which have comparable (and strong) interac-
tions to determine all three cell dimensions and close pack.
Thus, the fields of crystal engineering and self-assembly are
dominated by multicomponent systems (Ward & Raithby,
2013).
Hence, the crystal energy landscape, the set of crystal
structures generated by CSP methods which are sufficiently
low in energy to be thermodynamically plausible as potential
polymorphs, rarely unambiguously predicts that the molecule
can only crystallize in one structure. What the calculation does
provide is the set of structures in which different compromises
between all the intermolecular
interactions and the conforma-
tional flexibility provide approxi-
mately the same, most favourable
crystal energy. The CSP procedure
with an adequately exhaustive
search generates all reasonable
packing modes for the given
molecule, the analysis of which can
yield very valuable information
about the favoured modes of
packing of the molecule in its
various solid forms (Carlucci &
Gavezzotti, 2005; Gavezzotti,
2002). The variation in the number
of structures, their energy separa-
tion and most importantly, the
nature of the compromises,
depends on the specific molecule:
some of the molecule–molecule
contacts in the first coordination
shell are likely to be only weakly
stabilizing and hence readily
varied without significant change
in energy. Indeed, an estimated 9%
of crystal structures for non-
charged compounds contain a
destabilizing molecule–molecule
contact (Gavezzotti, 2010). Hence,
the majority of crystal energy
landscapes contain a variety of
crystal packings that are quite
close in energy to the most stable.
Do these thermodynamically
plausible structures represent
practically important polymorphs?
Experimental searches for solid
forms can produce a large number
of crystal structures containing a
given molecule, particularly if the
molecule is used in co-crystal
screening. Whilst there is a strong
relationship between the experi-
mental structural landscape
(Tothadi & Desiraju, 2012) and the
computed crystal energy landscape
of a molecule (Price, 2009), there
are usually more thermo-
dynamically feasible crystal struc-
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Figure 2
Molecular diagrams of some of the compounds whose crystal energy landscapes are discussed in the text.
Molecules IV, VI and XX retain the numbering used in the Cambridge Crystallographic Data Centre blind
test papers, and disrupt the sequence.
tures computed than known polymorphs. This article outlines
some of the reasons why, mainly based on the output of the
project ‘Control and Prediction of the Organic Solid State’ in
which experimental studies inspired, developed and validated
the calculation and interpretation of crystal energy landscapes.
The range of molecules for which CSP studies have proved
useful is shown in the key to the compounds discussed (Fig. 2).
This article seeks to illustrate the issues that need to be
considered before we could hope to predict the range of solid
forms of a given molecule, rather than reviews the use of CSP
as a complement to experimental solid-form screening. That
would be a huge and quickly outdated endeavour as, since it
was last attempted (Beyer et al., 2001), the rapid development
in the sophistication of both experimental screening and CSP
methods has shown the problems in defining a standard search
either in silico (CSP) or in silica (and other containers used in
solid-form screening). Hence, this article attempts to answer
the title question, or more precisely: Why do crystal structure
prediction methods usually generate more thermodynamically
feasible structures than known polymorphs?
1.1. Because of approximations in the calculations, particu-
larly the neglect of thermal effects
The energy differences between polymorphs are of the
order of 1 kJ mol1, which is a real challenge to the accuracy
of current computational methods, even expecting consider-
able cancellation of the errors in the necessary approxima-
tions. Hence, success in terms of usually getting the known
crystal structures as the most stable, or sufficiently close
(within the first three is the arbitrary criterion used for blind
tests of CSP) has been shown to require very computationally
expensive methods. These are all based on electronic structure
calculations on either the crystal structures (Chan et al., 2011a;
Neumann & Perrin, 2005) or the molecule in each plausible
conformation (Day, 2011; Price et al., 2010). No method in
current use was able to reliably calculate the relative lattice
energies for all the molecules in the last CSP blind test
(Bardwell et al., 2011). This is because the different types of
intermolecular and intramolecular forces that need to be
balanced in calculating the lattice energy depend considerably
on the type of molecule. We can estimate whether the theo-
retical underpinnings of a given type of crystal energy
evaluation is suitable for a given molecule, in terms of its size,
functional groups, likely conformational flexibility and inter-
molecular interactions, so that a CSP study is worthwhile. [A
CSP study is a waste of time if the computational method used
in the final optimization method does not reproduce the
known crystal structures of the molecule (or related mole-
cules) with reasonable energies.] However, it is the specific
molecule itself that determines whether it has one good way of
packing with itself, or a range of almost equally good
compromises, and hence the confidence with which the most
stable structure can be predicted. For example, when a simple
CSP method was used to calculate the crystal energy land-
scapes of the isomers of dichloronitrobenzene (Barnett,
Johnson et al., 2008), the 2,3-isomer was clearly found (by
1.75 kJ mol1 relative to its next best structure) as the struc-
ture with the lowest lattice energy. However, the success of
this method in finding the observed structures of other
dichloronitrobenzenes at their global minimum decreased as it
became less stable and also less distinct in energy from other
packings of the molecule. Hence, if, as in the cases discussed
below, the known structures are amongst the most stable on
the crystal energy landscape, and the relative energies of the
unobserved types of structures are not too sensitive to the
approximations in the calculations, the question as to why the
alternative structures are not observed polymorphs remains.
An obvious limitation of the lattice-energy based CSP
methods, emphasized by studies of atomic, ionic or molecular
crystals of small polyatomics, is that CSP calculations usually
are based on static lattice energies (i.e. the 0 K energies,
neglecting zero-point motions), rather than the free energies.
Molecular dynamics (MD) studies to include molecular
motions show that this can significantly reduce the number of
low-energy structures. A metadynamics study of benzene
(Raiteri et al., 2005) showed that the vast number of lattice
energy minima reduced to approximately the number of
known polymorphs. However, benzene does undergo facile
solid-state transformations. In contrast, a study of 5-fluoruracil
showed that 75% of the 60 most stable distinct lattice-energy
minima were also free-energy minima at 310 K (Kara-
mertzanis, Raiteri et al., 2008). This reluctance to transform is
consistent with the two polymorphs not showing any trans-
formation below the melting point (Hulme et al., 2005), as is
often observed when a pair of polymorphs have different
hydrogen-bonding motifs. Hence, the number of structures
which are energetically competitive at 0 K that are artefacts of
the neglect of the molecular motions within the crystal
structure is very dependent on the ease of solid-state trans-
formations between the (hypothetical) crystal structures.
Many organic solid-state polymorphic phase transforma-
tions are difficult, as once the molecule is close packed within
a crystal, there is a significant barrier to rearrangement. It has
been argued that all organic molecular transitions are first
order (Mnyukh, 2001), with the phase change requiring a
nucleation and growth mechanism, rather than a mechanism
that goes from single-crystal to single-crystal, maintaining
translational symmetry throughout. Certainly, even the solid-
state phase transformation of tetrachlorobenzene, which
occurs reversibly with no apparent loss in sample quality with
very subtle structural changes except in terms of crystal-
lographic symmetry, is first order with a sample-dependent
transformation temperature and hysteresis (Barnett et al.,
2006). The type of polymorphism that can be readily observed
by crystal to crystal transformation on changing the
temperature can come from the high temperature, higher
symmetry phase being a dynamic average over two lower
symmetry lattice-energy minima. Even zero-point motion can
average lattice-energy minima, giving rise to a higher
symmetry structure that is strictly a transition state in the
static lattice-energy potential surface. For example, the
powder X-ray diffraction pattern for racemic naproxen (III)
was a good match for the lowest energy structure found on the
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Z0 = 1 crystal energy landscape (Braun, Ardid-Candel et al.,
2011), but this was a transition state structure. Lowering the
symmetry gave a Z0 = 2 structure as a true lattice-energy
minimum, but the 1 kJ mol1 energy lowering only corre-
sponded to a minor shifting of layers and minor changes in
conformation, and so this structure was an equally good match
for the powder X-ray diffraction pattern. Solid-state NMRwas
used to confirm that structure was indeed Pbca Z0 = 1,
confirming the estimate that even the zero-point motions
would average over the Z0 = 2 Pca21 lattice-energy minima.
Hence, we often have far more lattice-energy minima than
free-energy minima. Short molecular dynamics simulations
can reduce the number of minima, and equilibrated simula-
tions can increasingly be applied to study phase transitions,
where the phase transitions can be observed. However, CSP is
most valuable in predicting polymorphs which are not readily
observed. In these cases, the dynamical simulation of the
crystal at a specific temperature is not going to reveal anything
– the molecular packing was determined during crystallization,
and expensive MD calculations probably will only show the
thermal expansion produced by the anharmonicity in the
lattice vibrations. Changes in which is the most stable poly-
morph with pressure, can, in principle, be readily predicted by
CSP by recalculating the relative energies as a function of
pressure (Kendrick et al., 2013).
1.2. Because of the molecular rearrangement during
nucleation and growth
Unless solid-state transformations are facile, the crystal
packing becomes fixed at the temperature and pressure at
which it is formed. It is the reorientation and conformational
changes of the molecules as they associate during the time
allowed for crystallization from the melt or solution that
determines whether a molecule crystallizes in the stable or
metastable form. If the crystal that is formed the fastest is
always the most stable, then it would normally not be possible
to observe polymorphism (Desiraju, 2007). However, when
the kinetics of crystallization favour a metastable structure,
then polymorphs will be observed. Discussions of Ostwald’s
Law of Stages (Threlfall, 2003), disappearing polymorphs
(Dunitz & Bernstein, 1995) and polymorph selectivity
(Blagden & Davey, 2003) all show the complexity of the
interplay between the kinetics of nucleation (Davey et al.,
2013) and growth (Yu, 2007). Although great progress is being
made in the computational modelling of nucleation (Anwar &
Zahn, 2011) and the relative growth rates of the crystal faces
(i.e. crystal morphology; Rohl, 2003; Schmidt & Ulrich, 2012)
as a complement to experimental investigations, we still know
very little about the competition between the kinetics of
alternative crystallization routes that lead to different poly-
morphs. Concomitant crystallization (Bernstein et al., 1999),
where different polymorphs crystallize in the same experi-
ment, demonstrates that this competition can be very finely
balanced. The search for conditions for producing phase pure
samples of different polymorphs is empirical and can be
frustrating: attempts to find conditions to obtain form III of
olanzapine (V) separately from form II have not yet been
successful, consistent with the likely relationship between the
structures deduced from the crystal energy landscape
(Bhardwaj et al., 2013).
The first nucleation of a new polymorph is a key event.
Difficulty in nucleating accounts for the late appearance of
new polymorphs such as form II ritonavir. Nucleation is
generally a sufficiently rare event that it is unlikely to be seen
in brute-force molecular dynamics simulations (Anwar &
Zahn, 2011): most simulation methods for studying nucleation
require the definition of a path or end structure. This is
problematic when experiment or CSP suggests there are many
thermodynamically competitive crystal structures as distinct
end points. A more practical approach to nucleation compe-
tition may be molecular dynamics simulations on nanocrys-
tallite clusters derived from the CSP competitive structures, as
applied to tetrolic acid in the two solvents that lead to
different polymorphs (Habgood, 2012). The change in relative
stability of polymorphs with size of nucleus has been
demonstrated for l-glutamic acid and d-mannitol, where small
cluster nanocrystallites of the bulk metastable phase are more
stable than clusters derived from the stable form (Hammond
et al., 2012).
Whilst our understanding of crystallization kinetics is so
limited, we can only qualitatively compare the structures on
the crystal energy landscape to assess whether they are so
similar that they are likely to correspond to the same structure
somewhere along the crystallization route. Are the structures
sufficiently different for it to be plausible that different
conditions would lead to their crystallization as distinct poly-
morphs? We are still at the stage of learning, by comparison of
the crystal energy landscape with experimental structures of
polymorphs, what differences in the computed structures
correlate with observable polymorphs. The development of
diverse methods of comparing dozens of crystal structures is
essential to this task. The analysis tools inMercury (Macrae et
al., 2008), such as calculating the optimum overlay of the
coordination cluster of the molecules between two crystals, or
the complementary analysis in terms of supramolecular
constructs by XPac (Gelbrich & Hursthouse, 2005; Gelbrich et
al., 2012), prove very useful in determining packing features,
such as dimers, stacks or layers, that are in common or differ
between the low-energy structures. Most recent applications
of crystal energy landscapes to rationalize the results of solid-
form screening on pharmaceutical-sized molecules rely
extensively on a combination of Xpac and hydrogen-bonding
analyses (Bhardwaj et al., 2013; Braun, Ardid-Candel et al.,
2011; Ismail et al., 2013; Kendrick et al., 2013; Montis et al.,
2012).
Qualitative estimates of whether two structures are so
closely related that only the more stable would crystallize, or
sufficiently different that there would be a barrier to inter-
conversion during nucleation, can be based on dominant
strong interactions or synthons (Desiraju, 2007). For example,
hydrogen bonds are generally expected to be sufficiently
strong that structures with different hydrogen bonding can be
expected to be observed as different polymorphs. This
lead articles
Acta Cryst. (2013). B69, 313–328 Sarah L. Price  More polymorphs? 317
assumption was behind the 2001 blind test discussion
(Motherwell et al., 2002), where two target molecules were
generally agreed to have structures with alternative hydrogen
bonding as competitive in energy to the known structures, and
so polymorphs of the target structures might be expected. A
new polymorph of 6-amino-2-phenylsulfonylimino-1,2-dihy-
dropyridine (VI) was later found, after 80 cell measurements
on single crystals, with the anticipated alternative hydrogen-
bonding synthon (Jetti et al., 2003). A third polymorph was
found later (Roy & Matzger, 2009) and these three structures
proved to be the most stable in a more recent CSP study
(Chan et al., 2011b). In contrast, it was only after 3-azabicy-
clo[3.3.1]nonane-2,4-dione (IV) had been resynthesized and
thermal analysis found a plastic phase that the strength of the
imide hydrogen bonding was considered (Hulme et al., 2007).
The spherical shape of the molecule and the weakness of the
electrostatic potential around the hydrogen-bonding proton
meant that doubly hydrogen-bonded dimers could easily
rearrange to give a hydrogen-bonded catemer. The automated
solvent crystallization screen did find a novel polymorph, and
two solvates, but all were based on catemeric hydrogen
bonding. The energy difference between the ordered crystal-
line polymorphs and the most stable, dimer-based unobserved
crystal structure was well within the error of the methods used
(0.6–2.1 kJ mol1), so the target structure in the blind test was
the thermodynamically stable form. Differences in hydrogen
bonding between the low-energy structures are easily spotted
by software that uses distance criteria, aided by hydrogen-
bond graph sets (Bernstein et al., 1995), but this is not a reli-
able guide as to whether the hydrogen bonds produce a
sufficient barrier to transformation to produce polymorphs.
The ability to trap molecules in metastable polymorphs
because they cannot rearrange readily can be associated with
larger functional groups and conformational flexibility. For
example, to discuss whether the fenamate group could be
considered a polymorphophore (Lo´pez-Mejı´as et al., 2009) we
analysed the Z0 = 1 crystal energy landscapes of monomorphic
fenamic acid (VIIa) and pentamorphic tolfenamic acid (VIIb)
(Uzoh et al., 2012). All low-energy crystal structures contained
carboxylic acid dimers with the two phenyl rings extending
like paddle wheels. In the isolated dimer the phenyl rings can
adopt a wide range of angles, limited only by steric clashes
between specific non-hydrogenic substituents. However, once
the phenyl rings from different dimers interdigitate in forming
the nucleus or crystal, the conformational flexibility is drasti-
cally reduced. This general type of argument helps explain
why most fenamates are polymorphic, with nonamorphic
flufenamic acid (VIIc) (Lo´pez-Mejı´as et al., 2012) rivalling
ROY (I) in the number of polymorphs that have been struc-
turally characterized. The crystal energy landscape of tolfe-
namic acid [like that of ROY (I); Vasileiadis et al., 2012] shows
structures that are competitive in energy and so may yet prove
to correspond to further polymorphs. In stark contrast, the
Z0 = 1 lattice energy landscape of fenamic acid (VIIa) had its
most stable structure equi-energetic with the only observed
structure (which is Z0 = 2 and so could not have been found in
the search). Both structures are closely related to the next
most stable computed structure, 2 kJ mol1 higher in energy,
which can be stabilized either by changing the torsion angles
of half the molecules to give the observed Z0 = 2 structure, or
by sliding the sheets to obtain the CSP-generated most stable
structure. Hence, it seems unlikely that fenamic acid will have
long-lived polymorphs, as the computationally generated
energetically competitive structure is too similar to the
observed form. A bromo derivative of ROY appears to be
monomorphic, although other derivatives are polymorphic
(Lutker et al., 2008). Hence, the common feature of the
fenamates (VII) and ROY (I) polymorphophores, of having
flexibly linked aromatic groups that can adopt a wide range of
conformations only until the molecules have associated, does
generally promote polymorphism. However, the crystal
energy landscape is needed to show whether or not the specific
substituents allow the range of molecular shapes to adopt
thermodynamically competitive structures and hence be
possible polymorphs.
Conformational flexibility clearly plays a significant role in
crystallization. The molecular conformations observed in
crystal structures are generally low in energy but how close
this is to a local or global minimum energy conformation for
the isolated molecule depends on the nature of the molecule.
Small molecules such as aspirin (VIIIa) (Ouvrard & Price,
2004) usually crystallize in a conformation that is sufficiently
close to a local minimum that there is only a minor difference
in the van der Waals surface. For molecules with two or more
rigid functional groups linked by flexible torsion angles, like
the fenamates (VII), the isolated molecule conformational
energy wells can be sufficiently shallow that the conformations
in crystal structures can be close in energy to a gas-phase
minimum, but the difference in the flexible torsion angles can
give rise to a different overall molecular shape (Uzoh et al.,
2012). The need to produce a densely packed crystal structure
competes with conformational preference, for example,
succinic acid adopts a planar conformation in the over-
whelming majority of its 56 predominantly cocrystal struc-
tures, whereas the most stable conformation is non-planar.
The non-planar isolated molecule structure cannot pack to
produce any crystal structures that are competitive in energy
with the known polymorphs (Issa et al., 2012), and whatever
the conformation of succinic acid in solution it can easily
become planar during crystallization. However, generally
crystal structure conformations are good guides to confor-
mational preferences in other phases (Cruz-Cabeza et al.,
2012). Indeed, for many small molecules the conformational
flexibility is such that searching with the rigid isolated mole-
cule conformation(s) and then adjusting the flexible torsion
angles within the crystal packing (Kazantsev, Karamertzanis,
Adjiman & Pantelides, 2011), to gain improvements in close
packing or hydrogen bonding (e.g. for OH and NH2 groups), is
a very effective strategy. However, when there are a wide
range of conformations corresponding to very different shapes
of the molecule which are low in energy, a different search
strategy is needed. Such strategies have been successful in
blind tests of CSP, for example, benzyl-(4-(4-methyl-5-(p-
tolylsulfonyl)-1,3-thiazol-2-yl)phenyl)carbamate (XX) (Bard-
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well et al., 2011; Kazantsev, Karamertzanis, Adjiman, Pante-
lides, Price et al., 2011) or the contrasting case of a very flat
two-dimensional conformational profile for 1-benzyl-1H-
tetrazole (X) (Spencer et al., 2012). It is challenging to eval-
uate a reliable conformational energy surface for larger
molecules, even in isolation, as the intramolecular dispersion
plays an important role. [For example, routine SCF calcula-
tions give a broad minimum in the conformational profile of
tolfenamic acid (VIIb), in the region which corresponds to a
local maximum ( 5 kJ mol1) for a range of higher quality ab
initio methods and a low population of experimental struc-
tures (Uzoh et al., 2012)]. A particular challenge to evaluating
relative lattice energies for conformational polymorphs is
when an intramolecular hydrogen bond in one polymorph
(and the gas phase) changes to being intermolecular in
another (Karamertzanis, Day et al., 2008). The problems in
modelling dispersion and polarization and all other contri-
butions to equal accuracy makes modelling even the lattice
energy accurately very demanding of current computational
chemistry methods (Kendrick et al., 2011; Price, 2008a).
Once the crystal energy landscape has been calculated, a
comparison of the conformations within the crystal structures
will reveal the range of conformations that can pack densely
with favourable intermolecular interactions. For example, for
olanzapine (V) there are two low-energy conformational
wells, but one conformation only produces one low-energy
structure which has such a low packing coefficient (Gavezzotti,
1983) that it is unlikely to be an observed polymorph
(Bhardwaj et al., 2013). However, in other cases, such as
GSK269984B (XI), the structures that are competitive in
energy (Fig. 1b) have such different gross conformations from
that observed in the three structurally characterized forms
(Fig. 3), that if formed, they would be long-lived polymorphs
(Ismail et al., 2013). Hence, the question arises as to how much
conformational rearrangement can occur during nucleation.
The degree of rearrangement possible during nucleation
and growth will be very dependent on the molecule and has to
be contrasted with the timescales of different crystallization
methods. Simple molecules which are liquids or gases at room
temperature may have plenty of time to rearrange to the most
stable form as they are cooled to low temperature, although it
is notable that a different polymorph is often produced by
crystallization under high pressure (Ridout & Probert, 2013).
The rarity of polymorphs in a screen of dichloronitrobenzenes
could be attributed to most crystallizations being performed
just below the melting points of these weakly interacting
molecules (Barnett, Johnson et al., 2008) implying consider-
able scope for the rearrangement of any metastable poly-
morphs. At the other extreme, it may be that the effective
building block for crystallization is determined at the earliest
stages of crystallization. There are established correlations
between the prenucleation clusters observed in different
solvents, either experimentally or in simulations (Davey et al.,
2013), and the polymorph formed. The formation of preferred
pre-nucleation aggregates or conformations could be even
more pronounced for larger, flexible molecules. Olanzapine
(V) forms a centrosymmetric dimer in all 59 solid crystalline
forms (three polymorphs, seven groups of isostructural
solvates; Bhardwaj et al., 2013), but the crystal energy land-
scape includes other structures which do not contain the dimer
but have molecular sheets in common with the known forms.
Since the dimer interaction dominates the lattice energy of the
known polymorphs it is clearly tempting to assume that the
dimer forms so early in the molecular association, prior to
nucleation and growth, possibly dominating the solution
structure, that it is not possible to nucleate structures without
this motif. We are still very much at the early stages of being
able to detect and understand how kinetic factors determine
which thermodynamically feasible crystal structures could be
kinetically trapped as metastable polymorphs.
1.3. Because the structures can be present in disordered or
solvated crystals and other phases
Cyclopentane adopts the lowest lattice-energy structure
below 123 K (at low pressure), but then has an intermediate
dynamically disordered phase, before transformation above
137 K to the high-temperature cubic phase. This behaviour
can be rationalized as the increasing dynamical motion with
temperature sampling an increasing number of the multitude
of very closely spaced lattice-energy minima (Torrisi et al.,
2008). Thus, one way of interpreting plastic or dynamically
disordered phases is that the molecules are moving between
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Figure 3
The conformational issues that can arise in interpreting a crystal energy
landscape of a flexible pharmaceutical GSK269984B (XI): (a) overlay of
the ab initio optimized isolated molecule conformation (red) with the
conformations in all the crystal structures obtained in an extensive
experimental screen guided by the crystal energy landscape (Ismail et al.,
2013); the only single component structure (atomic colours), the N-
methylpyridone (blue) and a 1:2 dimethylsulphoxide (orange) solvate; (b)
overlay of the observed conformation (atomic colours) and that in the
next most stable calculated structure (light green) on Fig. 1(b). ’ is the
angle used to classify the structures.
the large number of almost equi-energetic lattice-energy
structures: i.e. the low-energy barriers between the different
structures produce dynamic disorder giving rise to high-
symmetry structures. Thus, distinct lattice-energy minima
separated by low-energy barriers can correspond to the same
experimental structure, i.e. many of the low-energy structures
are ‘observed’ within the dynamically disordered high-
temperature phases. The distinction between dynamic and
static disorder is complex, depending on the temperature and
the barriers for correlated motions of the molecules and in
practise will depend on the size and defects of individual
crystals. Indeed, for all molecules, configurational and thermal
entropy will lead to disorder at some temperature before or at
the melting temperature. Hence many polymorphs are
observed by thermal microscopy (Kuhnert-Brandstatter,
1982), although isomorphic seeding, sublimation and quench
cooling can be involved.
Static disorder is likely when the crystal energy landscape
contains two or more structures that are so closely related
both in structure and energy that it is hard to imagine mole-
cules being able to assemble into perfect ordered crystals of
either structure (van Eijck, 2002). This static disorder has been
demonstrated in the case of eniluracil (XII) where there are
many low-energy structures (Copley et al., 2008) which are
effectively the same if you do not distinguish between the
C4 O and C6—H groups. These two groups are not involved
in forming the hydrogen-bonded ribbons and barely affect the
interdigitation of the ethynyl groups. These crystal structures
are sufficiently close in energy that configurational entropy
stabilizes a disordered structure (Habgood, Grau-Crespo &
Price, 2011). Careful analysis of the diffraction from four
different single crystals, grown from two sets of similar
conditions, confirmed that the structures were indeed disor-
dered, with the site occupancy factors of the major component
varying between 0.70 and 0.84 for the different crystals
(Copley et al., 2008). In this case, different individual struc-
tures had been proposed by structure solution from powder X-
ray diffraction data, and even single-crystal diffraction data
could reasonably have been interpreted as polymorphism. It
seems more reasonable, given the crystal energy landscape, to
view eniluracil crystallization as being intrinsically disordered,
with the degree of disorder being dependent on crystallization
conditions. This disorder is seen in isostructural 5-chlorouracil
and 5-bromouracil, and indeed this symmetric ribbon motif is
commonly found in the crystal energy landscape of uracils
with a small functional group at the 5 position. However, the
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Figure 4
Analysis of the structures on the crystal energy landscape of phloroglucinol dihydrate (XIV) (Braun et al., 2012). Group A (green triangle) structures
match the proton disordered experimental structure, whereas group B (blue diamond) structures differ in the layer structure and so provide a model for
the intergrowths that result in morphological features and diffuse scattering. Top, left to right: the hydrogen-bonding directionality which produces the
proton disorder in the average X-ray structure below, protons are otherwise omitted for clarity: the two hydrogen-bonded chains of phloroglucinol and
water (red) molecules, whose contrasting layer structures support the intergrowth structure below. The energy differences between these structures
support this model for the disorder.
nature of the substituent determines the differences in energy
between the various packings of the symmetric ribbon and the
many other hydrogen-bonding motifs which can be generated
and observed for 5-uracils (Barnett, Hulme et al., 2008).
An important, but arguably small, difference in unique
structures on the crystal energy landscape is when they differ
only in some proton positions, and yet have very similar
energies. Structures which differ only in the directionality of
the hydrogen bonds, e.g. O—H  O versus O  H—O, have
frequently been found in the crystal energy landscapes of
hydroxybenzoic acids, such as gallic acid (XIII), and their
hydrates (Braun et al., 2013). Proton positions are not always
readily determined by crystallographic methods, and hence
some methods of structural comparison would not consider
such structures as different, and cases of proton disorder are
likely to be under-reported. Judging from the computed
crystal energy landscape, proton disorder seems probable for
the metastable monohydrate of 2,4-dihydroxybenzoic acid
(Braun, Karamertzanis & Price, 2011). The 50:50 disorder in
one hydroxyl and water protons in phloroglucinol dihydrate
(XIV) suggested by the crystal energy landscape (Braun et al.,
2012) is implicit in the crystallographic symmetry. However,
the observed variation in morphology and diffuse scattering of
phloroglucinol dihydrate appears to arise from the disorder
introduced by the proportion of packing faults represented by
the close relationship between corrugated and cascaded layer
structures on the crystal energy landscape (Fig. 4).
There are many other cases where the crystal energy
landscape shows structures that have the same sheet stacked
differently, which are close in energy. This phenomenon was
observed on the crystal energy landscape of aspirin (VIIIa),
which at the time was believed to be monomorphic, and the
high susceptibility to shear was used to rationalize why the
structure with the alternative stacking of layers was not
observed (Ouvrard & Price, 2004). This structure was later
found, although metastable (Vishweshwar et al., 2005), and
single crystals of aspirin were found to contain domains of
form II and form I as intergrown structures (Bond et al., 2007).
Crystallization of aspirin in the presence of aspirin anhydride
(VIIIb) has since been found to produce single crystals of
form II which are very long-lived (Bond et al., 2011). Hence,
when the crystal energy landscape has nearly equi-energetic
structures containing the same layer yet stacked in different
ways, whether crystallization will lead to only one structure
probably with some stacking faults corresponding to the
alternative stacking, polytypism, polymorphic domains or
polymorphs can be very sensitive to both crystallization
conditions and the definition of the distinctions in this conti-
nuum of structures. Quantification of stacking disorder
through lattice-energy calculations has recently been used to
explain the stacking disorder in tris(bicyclo[2.1.1]hex-
eno)benzene (Schmidt & Glinnemann, 2012). This type of
calculation for evaluating the configurational entropy from the
lattice energies of an ensemble of ordered supercells, gener-
ated by a site-occupancy disorder model (Habgood, Grau-
Crespo & Price, 2011), has been applied to eniluracil (XII), the
formation of a solid solution of p-dichlorobenzene and p-
dibromobenzene and the low-temperature structure of
caffeine (XVa) (Habgood, 2011). Evaluation of configura-
tional entropy requires the definition of likely disorder
components, which can be derived from the crystal energy
landscape (Habgood, 2011). Disorder components will corre-
spond to near-symmetry in the intermolecular interactions
(e.g. there is almost a mirror plane in the electrostatic
potential on the van der Waals surface of the molecule but not
in the molecular diagram) and results in there being almost
equi-energetic low-energy structures on the crystal energy
landscape, related by the disorder model (Figs. 5 and 1c). The
closely spaced lattice-energy minima can be considered as
observed structures since they are members of the symmetry-
adapted ensemble of structures that contribute to the entropic
stabilization of the observed disordered structure.
Even without quantification of configurational entropy, the
relationships between closely spaced structures on the crystal
energy landscape quickly give a rationalization of complex
crystallization behaviour, and can help characterize structures.
For example, a Z0 = 1 CSP study of chlorothalonil (XVI)
(Tremayne et al., 2004) produced two layer structures that
correlated with the high-symmetry disordered layer structure
of form 2 and two herringbone structures that had very similar
powder patterns, and eventually proved to be components of
the Z0 = 3 single-crystal structure of form 3. All four ‘observed’
structures were within 1.25 kJ mol1 of the global minimum
structure, which corresponded to the stable form 1. A more
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Figure 5
Disorder in caffeine (XVa): (a) An ordered representation of the
structure of form II caffeine (Enright et al., 2007) with the ordered
molecule in atomic colouring, and the two independent disordered
components in red and blue. The stacking was used to classify the
structures on the crystal energy landscape in Fig. 1(c) (i.e. stack 1 atomic,
stack 2 red, stack 3 blue). (b) The electrostatic potential on the van der
Waals surface plus 1.2 A˚ for caffeine; +1.5 V corresponds to an
interaction energy of +1.4 kJ mol1 with a positive point charge of
0.01 e. The experimental structure has disorder components corre-
sponding to rotation by 180 about the two marked axes (Habgood,
2011), with the heavier dashed line corresponding to the blue disorder
component which has greater approximate symmetry in the steric and
electrostatic interactions of the molecule than the red component which
corresponds to a crystallographic axis.
extensive search, including higher Z0 structures or more space
groups, would have increased the number of related structures
well within the energy range of plausible polymorphism, and
similarly increasing the experimental search would be
expected to find more structural variations.
The formation of solvates as disordered intermediates or
final products of crystallization also needs considering. The
crystal energy landscape of a DMSO solvate of carbamazepine
(XVIIa) (Cruz-Cabeza et al., 2011) suggested the solvent
disorder seen in the low-temperature crystal structure, and in
the dynamically disordered high-temperature phase. Solvent
can be undetected due to its mobility within the crystal
structure, which, since the solvent stabilizes the structure, may
mislead the interpretation of the relative stability of observed
polymorphs. Investigations prompted by the relatively high
lattice energy of carbamazepine form II (Cruz-Cabeza et al.,
2007a) showed that solvents move quite freely in the channels.
Only recently have water wires in these hydrophobic nano-
pores of carbamazepine form II been observed by single-
crystal X-ray diffraction (Prohens et al., 2013). On the other
hand, no experimental evidence could be found for water in
the channels of a diastereomeric salt (R)-1-phenylethyl-
ammonium-(S)-2-phenylbutyrate (XVIII) to account for why
the observed structure was quite high in energy on the crystal
energy landscape (Antoniadis et al., 2010). Frameworks, layers
or other bimolecular packing motifs seen in isostructructural
and disordered solvates are often on the crystal energy land-
scape of molecules which are much larger than solvent
molecules, such as olanzapine (V) (Bhardwaj et al., 2013) and
(hydro)chlorothiazide (XIX) (Johnston et al., 2007, 2011).
Indeed, the framework structures of inclusion compounds
which can contain a variety of guests have been found as low
density, higher-energy structures on the crystal energy land-
scape of the framework molecules (Cruz-Cabeza et al., 2009).
CSP has also been able to predict the assembly of porous
organic molecular crystals (XXVI) (Jones et al., 2011), a case
where the exact nature as well as disorder in other compo-
nents present is irrelevant.
An extreme example of disorder is gel formation, where
small molecules are dispersed within the solid phase. CSP
studies on two chemically similar functionalized dipeptides
(XXI) showed that the one which forms a meta-stable
hydrogel prefers to pack as tightly coiled molecular columns,
whereas this mode of packing is not found for the other
dipeptide that forms a crystalline solid (Adams et al., 2010).
Low-energy CSP structures for melamine uric acid dihydrate
gave sufficiently close matches to the PXRD pattern of the
dried xerogel to give insight into the gel structure formed by
sonication of an aqueous solution of melamine and uric acid
(Anderson et al., 2008).
Another extreme form of disorder is the amorphous solid
state. Analysis of the crystal energy landscape of salsalate
(XXII) reveals a pair of hydrogen-bond motifs that appear to
be severely detrimental to the molecule’s ability to pack effi-
ciently and stably, indicating an explanation for the formation
of a stable amorphous phase (Habgood et al., 2013). Concur-
rent experimental work suggests that impurities from thermal
degradation may also play a role in frustrating crystallization.
Conformational flexibility and size may help, but are not
necessary for the formation of an amorphous state. The
polyamorphous nature of carbonic acid (XXIII) also appears
to be rationalized by two different conformations of carbonic
acid having a multitude of crystal packings of similar energies
(Winkel et al., 2007).
Thus, analysis of the structures on the crystal energy land-
scape often suggests that there are problems in forming a
close-packed ordered solid. If these result in difficulties in
growing a crystal suitable for single-crystal diffraction, then it
can be difficult to determine the existence and nature of the
disorder, and the CSP generated structures can support
experimental progress in determining structures of disordered
through to amorphous solids. It appears that some of packing
relationships in the low-energy structures are observed, but
only at the molecular level as disorder within the solid forms.
For larger molecules, some of the calculated structures for a
given molecule are closely related to the molecular packing
observed in solvated structures, where the solvent acts as a
space-filler and may be disordered. Indeed, desolvating
solvates can be an important route to new polymorphs (Braun
et al., 2013; Ismail et al., 2013), emphasizing that the point at
which the solvent is expelled during crystallization can vary.
Thus, some metastable structures on the single component
crystal energy landscape reflect the packing in loosely solvated
solid forms. Conversely, the interplay between thermo-
dynamics and kinetics in different multi-component crystal-
lization routes can lead to even the most stable structure on
the crystal energy landscape not being observed.
1.4. Because the structures are metastable relative to other
molecular compositions
CSP methods will always generate crystal structures with
the molecules in the stoichiometry specified: searches with
more than one molecule in the asymmetric unit cell are
considerably more demanding because of the need to consider
the different relative positions of the molecules within the
asymmetric unit. The individual search does not tell you
whether even the most stable structure generated is going to
be more stable than the components or another stoichiometry
and hence could be observed. Analysis of the structures
generated can be highly suggestive. For example, the lowest
energy structures generated for a hypothetical 1,4-dicyano-
benzene:succinic acid cocrystal have layers of succinic acid
molecules alternating with layers of 1,4-dicyanobenzene
molecules, with the layers closely resembling the structures in
succinic acid and 1,4-dicyanobenzene polymorphs. Given that
this is the most favourable type of structure for the cocrystal, it
is not surprising that no cocrystal was found in an extensive
experimental search (Issa et al., 2012). Similarly CSP searches
for urea:acetic acid (1/1) produced structures with unsatisfied
hydrogen-bonding donors; urea:acetic acid (1/3) had an acid
molecule which was only filling space and not hydrogen
bonded to urea, whereas the urea:acetic acid (1/2) structures
had ribbons which satisfied all the hydrogen bonding (Cruz-
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Cabeza et al., 2008). The second most stable structure for
urea:acetic acid (1/2) corresponded to the observed crystal,
although this was only stable in the mother liquor. Comparing
the relative lattice energies of urea and three acetic acid
molecules in various single and multicomponent structures did
give the 1:2 structure as thermodynamically preferred, but the
energy difference was small (Cruz-Cabeza et al., 2008). There
is considerable variability in the energy differences between
different stoichiometries of solvates, and this approach was
able to determine the structure of a novel acetic acid solvate of
theobromine produced by grinding (Cruz-Cabeza et al., 2010).
The prediction of whether a structure will form, by
comparing lattice energies as evaluated using the same
computational model for either known or lowest energy
structures, is obviously a crude model when it comes to
hydrate prediction: the comparison is with the ice polymorphs.
Comparison of stoichiometric ordered hydrate lattice energies
with those of the anhydrate and ice form XI showed that the
stabilization of the hydrate was generally small, and sensitive
to small changes in conformation of, for example, the OH and
NH2 groups of otherwise rigid molecules (Hulme & Price,
2007). Later CSP hydrate studies modelling molecular flex-
ibility, polarization within the crystal, and comparing with the
energy range of ice polymorphs, was able to rationalize why
2,5-dihydroxybenzoic acid forms no hydrates, despite being
subjected to the same screening that found a stable hemi-
hydrate and metastable monohydrate for 2,4-dihydroxbenzoic
acid. Despite structural differences in the hemi-, mono- and
dihydrates generated, the dominant reason for the hydrate
formation was that 2,4 dihydroxybenzoic acid is less stable and
less dense in the anhydrous phase than its isomer (Braun,
Karamertzanis & Price, 2011).
Cocrystals might be expected to be more readily predict-
able, and indeed a CSP search found only two carbamazepi-
ne:isonicotinamide cocrystal structures with lattice energies
lower or comparable with the lattice energies of the most
stable polymorphs of the components, corresponding to the
two polymorphs of this cocrystal (Habgood et al., 2010). This
study also showed that the lack of stable cocrystals of carba-
mazepine with the isomer picolinamide arose from the
difference in intermolecular hydrogen-bonding capability.
More complex differences in cocrystallization behaviour, in
terms of structure and stoichiometry, of caffeine with 2-, 3- and
4-hydroxybenzoic acid have also been explained by CSP
studies (Habgood & Price, 2010). Thus, CSP can be very
effective for generating structures of cocrystals (Kara-
mertzanis et al., 2009), but the energy differences between
cocrystals and components are generally of the order of
polymorphic energy differences (Issa et al., 2009) and so
require very accurate evaluation (Chan et al., 2013). Cocrystal
formation may not be in kinetic competition with the forma-
tion of the most stable polymorphs of both components, and
the experimental thermodynamic advantage of cocrystal
formation can be small and a balance of many small energy
terms (Oliveira et al., 2011).
Proton migration can also mean that a CSP generated
structure does not form. The distinction between a salt and a
cocrystal affects regulatory issues for active pharmaceutical
ingredients, producing intense debate (Aitipamula et al.,
2012). Even crystallization of simple pyridines with carboxylic
acids can result in a salt, cocrystal or disordered solid form as
defined by the acidic H-atom position, when the difference in
pKas is small (Mohamed et al., 2009). The proton position is
very important for computer modelling of the solid phases.
This is emphasized by comparing the crystal energy landscapes
of pyridinium carboxylate salts and the corresponding pyri-
dine carboxylic acid co-crystals (Mohamed et al., 2011): the
experimental salt or cocrystal was found low in energy on the
lattice energy landscape with the correct proton connectivity,
but only the proton disordered system had its structure low in
energy on both landscapes. In addition, despite the similarity
of the ionized and neutral forms of the carboxylic acid-
  pyridine heterosynthon, there are hydrogen-bonding motifs
that are only favourable for the salt or for the cocrystal. The
importance of proton position has recently been emphasized
by the discovery (Schmidt et al., 2011) of tautomeric poly-
morph IV of barbituric acid (XXIV), as the thermo-
dynamically stable phase at ambient conditions, whereas the
keto tautomer is the most stable in the gas phase, solution and
in polymorphs I–III. Crystal energy landscapes can be calcu-
lated for different protonation states to provide insight into
the different types of crystal packings available for a given
chemical diagram. However, comparing the energies of the
different global minima to determine which is thermo-
dynamically favoured requires ionization potentials and
tautomeric energy differences to too great an accuracy for
current computational methods and the approximations made
in creating the thermodynamic cycles. The crystal structures
found experimentally depend on how protons, solvent or other
components present can rearrange themselves during the
crystallization process. The permutations in crystallization
conditions can seem infinite, reflecting McCrone’s point about
the number of polymorphs found being proportional to time
and money put into research on that compound (McCrone,
1965). Crystal energy landscapes do provide an upper limit on
the range of practically important polymorphs, but there is a
need to consider competition with alternative phases and
isomers.
1.5. Because the right crystallization experiment has not yet
been performed
Interest in CSP has been aroused by the late discovery of
polymorphs corresponding to calculated low-energy struc-
tures, for example, form II aspirin in a failed cocrystallization
experiment (Vishweshwar et al., 2005), form II 5-fluorouracil
by crystallizing from dry nitromethane (Hulme et al., 2005) or
form II maleic acid in an attempt to recrystallize a caffeine–
maleic acid cocrystal produced by grinding (Day et al., 2006).
The serendipitous finding of new polymorphs of substances
that have been heavily studied (which can be calamitous if it
leads to disappearing polymorphs) emphasizes the impossi-
bility of experimentally covering all types of crystallization
conditions that have led to the discovery of a new polymorph
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of any molecule (Llina`s & Goodman, 2008). Hence, the desire
to use crystal structures to design crystallization experiments
to target structures that are ‘predicted’ once the factors xx1.1–
1.4 have been considered.
This has been demonstrated in the case of carbamazepine
(XVIIa), a generic anti-epileptic that has been extensively
used in polymorphism studies. The first four polymorphs all
contain the R22ð8Þ amide hydrogen-bond dimer, with this type
of hydrogen-bonding motif occurring in all the 50 ordered
solid forms (Childs et al., 2009). The first CSP study on
carbamazepine (Florence, Johnston et al., 2006) was therefore
surprising in showing a catemeric structure as slightly more
stable than the most stable observed polymorph. Other, more
accurate calculations revised this stability order (Cruz-Cabeza
et al., 2006; Welch et al., 2008), but the catemeric form
remained thermodynamically plausible. Extensive searching
for this polymorph using an automated system, using 66
solvents and 5 different crystallization protocols failed to find
a new polymorph (Florence, Johnston et al., 2006), although
this also did not find form IV which had been found by
polymer templating (Grzesiak et al., 2003). Cruz-Cabeza et al.
(2007b) suggested that there was a kinetic disadvantage for
carbamazepine to form strained hydrogen-bonding chains.
Crystallizing carbamazepine with the closely related molecule
dihydrocarbamazepine (XVIIb) led to a solid solution (Flor-
ence, Leech et al., 2006), which was isostructural with the
catemeric dihydrocarbamazepine form II, showing carbama-
zepine could form the required hydrogen bonds. Finally,
subliming carbamazepine onto a crystal of dihy-
drocarbamazepine form II led to the formation of the first
crystals of carbamazepine form V, the targeted isostructural
form (Arlin et al., 2011). Thus, polymorph screening on closely
related molecules yielded a crystal that could template a
targeted polymorph.
Less specific properties of the low-energy crystals may be
useful in designing crystallization strategies. Examination of
the hydrogen bonding can suggest that experiments in specific
solvents may be worthwhile (Cross et al., 2003), whereas
denser structures could be targeted by crystallization under
pressure (Fabbiani & Pulham, 2006; Kendrick et al., 2013).
However, the range of polymorphs is clearly limited by the
ability to vary the crystallization conditions sufficiently to
change the mode of self-assembly.
1.6. Because the right crystallization experiment cannot be
performed
The physical properties of many molecules can severely
limit the range of crystallization experiments that are feasible.
For example, our extensive searches for polymorphs within the
5-uracil family were severely limited by thermal instability and
limited solubility (Barnett, Hulme et al., 2008). There can be
difficulty in crystallizing at all (Baird et al., 2010; Hursthouse et
al., 2009); indeed, stabilizing amorphous phases or the design
of new ionic liquids (Dean et al., 2009) relies on preventing
crystallization. Since the main value of CSP is to assess the risk
of ‘unexpected’ crystallization outcomes, the challenge is to be
sure that a calculated low-energy crystal structure could never
be found, or at least not within the process conditions for an
industrial product.
Let us consider an ‘ad absurdum’ example. The crystal
energy landscape of progesterone (XXVa), considering all
common space groups for an organic molecule, predicts that a
racemic crystal is more stable than the two known forms.
However, progesterone naturally occurs as a single enan-
tiomer: the predicted racemic structure could only be
experimentally realised by crystallizing natural progesterone
with its synthetically produced mirror image molecule
(Lancaster et al., 2006). In this case, we could be confident that
no crystallization of natural progesterone could lead to the
racemic crystal structure without the deliberate addition of the
synthetic ent-progesterone. However, other chiral molecules
can racemize, indeed some very efficient chiral separation
processes have been devised, based on having a racemization
equilibrium going on at the same time (Noorduin et al., 2008).
It is a lot easier to exclude racemization than it is to exclude
the possibility of a significant conformational change. This
becomes a major issue when considering larger, flexible
molecules. For example, in the last blind test (Bardwell et al.,
2011) some groups included both cis and trans amide confor-
mations of the model pharmaceutical (XX) in their searches,
whereas others made the reasonable assumption that it was
trans. The question becomes increasingly difficult when the
barriers to gross conformational changes are smaller. For
example, the only anhydrate polymorph found in extensive
screening of GSK269984B (XI) was confirmed by the crystal
energy landscape to be the thermodynamically most stable
form (Ismail et al., 2013). However, there were thermo-
dynamically competitive structures which differed markedly in
conformation, both in gross shape and in having inter-
molecular instead of intramolecular hydrogen bonds (Fig. 1b).
Further experimentation targeting conformational change did
find novel solvates, which had intermolecular hydrogen bonds.
However, their structures revealed that only the carboxylic
acid proton conformation had changed: the anhydrate and
solvates all had essentially the same conformation as the
isolated molecule (Fig. 3). Other conformations exist in solu-
tion, as expected from the conformational analysis. How could
we target the conformational polymorphs, or diagnose that
they could not nucleate in a given manufacturing process?
The crystal energy landscape can contain ‘disappearing
polymorphs’ (Dunitz & Bernstein, 1995), and understanding
problems of reproducing recipes for polymorphs (Threlfall,
2000) may help devise experiments to stabilize or exclude low-
energy structures from being realisable polymorphs. For
example, attempts to crystallize form II progesterone (XXVa)
failed until it was found concomitantly with form I and a
pregnenolone (XXVb):progesterone (XXVa) cocrystal. This
allowed the crystal structure of form II to be redetermined
from a single crystal, but all samples converted to form I
(Lancaster et al., 2007). Analysis of a 50-year old form II
sample showed that it contained 11 impurities totalling 4.8%,
whereas a form I sample from the same period had only 3
totalling 1.9% (Lancaster et al., 2011). Since the impurity
lead articles
324 Sarah L. Price  More polymorphs? Acta Cryst. (2013). B69, 313–328
profile of modern sources of progesterone is totally different,
it appears that the crystallization conditions that in the past
would produce very ‘long lived’ form II progesterone cannot
be reproduced. This is in contrast to other cases where an
impurity can be specified and used to produce a given poly-
morph, for example 1 mol% ethamidosulfathiazole is needed
to produce form I sulfathiazole (Blagden et al., 1998). Thus,
whether or not certain metastable, low-energy structures are
observed as practically important polymorphs can be a matter
of whether the right additives or impurities are present.
1.7. Because the polymorphs are not detected or structurally
characterized by current techniques
Our database of calculated crystal energy landscapes
currently covers over 150 molecules plus 40 two-component
systems of fixed stoichiometry (salts, co-crystals and hydrates).
This sample is not statically meaningful, not only in terms of
numbers and bias towards small rigid molecules, but also in
the reasons why the systems were chosen for study. A further
bias (shared by the CSD) is towards systems where at least one
crystal suitable for single-crystal X-ray diffraction has been
grown. Huge advances in instrumentation are producing a
rapid change in the types of crystals whose structures can be
determined (Bond, 2012). The use of crystal energy landscapes
to help characterize or add confidence to structures derived
from powder X-ray diffraction is becoming well established.
This varies from providing the first crystal structures of
pigments (Schmidt et al., 2010) to determining the structure of
a novel polymorph (Perrin et al., 2009) or the racemic form
(Braun, Ardid-Candel et al., 2011) when single crystals can
only be grown for other packings, to solving ambiguities in
proton positions (Wu et al., 2013). Currently less established
uses include solving the crystal structures from high-resolution
1H solid-state NMR (Baias et al., 2013; Salager et al., 2010) or
from electron diffraction patterns (Eddleston et al., 2013b).
The application of transmission electron microscopy to find
crystallites with distinct morphologies and use CSP to help
determine the crystal structure of theophylline (XVc) form VI
is particularly noteworthy, as the new polymorph occurred in a
mixture with form II at a concentration below the limits of
detection of analytical methods routinely used for pharma-
ceutical characterization (Eddleston et al., 2013a). Investiga-
tions of the relationship between the (disordered)
polymorphic structure and the phonon modes are becoming
increasingly complemented by calculations (Li et al., 2010).
Thus, current limitations in detection and characterization
techniques can be a further reason why we do not find more
polymorphs. As we improve the methods and approximations
used to calculate spectra from increasingly accurate computed
structures, there will be an increase in the number of poly-
morphs characterized because CSP helped provide confidence
in the structure.
2. Conclusions – where are we now?
CSP calculations are now at a stage where they can be used to
answer the question ‘what types of alternative packings are
thermodynamically competitive with the known crystal
structures?’. This can valuably limit the range of possible
structures. For example, this explains why certain molecules
defy Etter’s rules and crystallize with unused hydrogen-bond
acceptors (Lewis et al., 2005). The comparison of the
computer-generated structures with all the experimental
crystal structures containing the molecule, and each other, is
often the most important and human time-consuming step in
CSP studies. As the examples discussed above show, the
crystal energy landscape frequently raises the question; are
there more polymorphs to be discovered?
It is quite unusual that the crystal energy landscape will
show that the molecule has a unique way of packing with itself,
and so a CSP study can confidently say that there are no
possible polymorphs. Our most confident prediction of
monomorphism is for isocaffeine (XVb) (Fig. 1a). The
contrast with the crystal energy landscape of its isomer
caffeine (XVa) (Fig. 1c), which has only been observed in
static and dynamically disordered phases, underlines the
difficulty of even qualitative crystal structure prediction
without CSP studies. It is thus rare that CSP-generated crystal
energy landscapes do not require structural analysis and
human interpretation. As experimental capabilities increase,
and as crystal energy landscapes are calculated for increas-
ingly complex systems, the rules for interpreting the land-
scapes are emerging. The above reasons for why the
thermodynamically feasible structures may or may not be
potential polymorphs give some qualitative guidance on
points to consider. The individual studies illustrate how the
molecule-specific considerations complement experimental
investigations of its solid form diversity, but often these studies
suggest that further research, either on the molecule or in
developing experimental or modelling techniques is desirable.
The further work required depends on the reasons why the
CSP study was undertaken and is often limited by the
resources currently available. It depends critically on the
range of structures on the molecule’s crystal energy landscape
and the barriers to transformation between them at some
point during the crystallization process. If the aim is solely to
determine the relative stability of the structures (or compete
in blind tests of CSP), then the range of structures determines
which approximations in calculating the crystal energy land-
scape need assessing to estimate the uncertainty in the
ranking. If there is a large spread in densities, free-energy
calculations are likely to rerank structures that are close in
lattice energy, whereas if there are significant differences in
conformation and types of hydrogen bonding then it is more
effective to assess the sensitivity to different approaches of
lattice energy calculation and quality of wavefunction. It can
be desirable to contrast a range of different electronic struc-
ture based methods of calculating lattice energies (Gelbrich et
al., 2013; Habgood, Price et al., 2011). If the aim is to interpret
the experimental evidence for additional polymorphs or forms
of disorder, then comparisons of calculated spectra or
diffractograms and the link between the structures and
observed transformations may give a very strong indication of
the type of structure responsible. If the aim is to find an
lead articles
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alternative solid form with a better compromise of properties
for manufacture or formulation, such as solubility, mechanical
or morphological properties, then estimates of these proper-
ties are required. This may then lead to the desire to target the
finding of a specific polymorph, using the structure to suggest
possible templates or types of experiment. Alternatively, the
aim may be to establish that energetically competitive struc-
tures are unlikely to emerge in a specific manufacturing
process.
Crystallization of organic molecules is often a complex
interplay between thermodynamics and kinetics when the
thermodynamic driving force barely differentiates between
the structures. Theoretically, we can define a path to the
prediction of the most stable phase as a function of
temperature and pressure, and whether it is ordered or
disordered, but doing this reliably for all but the simplest
molecules is a huge challenge to the development of compu-
tational chemistry techniques (Gavezzotti, 2002). The reliable
prediction of practically useful polymorphs, or the crystal-
lization conditions to reliably and reproducibly crystallize
even the most stable phase, requires better fundamental
understanding of crystallization processes appropriate to the
range of structures on the crystal energy landscape. We need
much greater molecular understanding of nucleation (Davey
et al., 2013) and of how different crystallization conditions,
including solvents, impurities and surfaces (Carter & Ward,
1993), can direct the formation of different solid forms before
we can routinely design an experiment to lead to a desired
polymorph, or conclude that it could never be found.
Hence, the current and future uses of calculated crystal
energy landscapes are as a complement to experimental
studies. Some of the structures on the lattice energy landscape
are artefacts of the neglect of temperature and other inac-
curacies in the modelling. However, even when we can
calculate realistic free energy landscapes, the question as to
whether the structures are sufficiently different to be observed
polymorphs will often remain. As the examples cited above
illustrate, we do not yet know enough about the kinetic factors
that can lead to the crystallization and longevity of metastable
solid phases to answer this question, let alone produce soft-
ware capable of predicting all polymorphs and the experi-
mental conditions for finding them. However, calculated
crystal energy landscapes can be used as part of the inter-
disciplinary work needed to fully understand and characterize
the solid state of organic molecules.
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